APG

APi Group Corporation

$42.07

+0.50%
Nov 20, 2026
Bobby Quantitative Model
APi Group Corporation is a $19.3 billion market-cap industrial services holding company operating through two segments: Safety Services (life safety, fire protection, HVAC, and entry systems — design, installation, inspection, and service) and Specialty Services (infrastructure and specialized industrial plant maintenance for electric, gas, water, sewer, and telecom networks), serving commercial, education, healthcare, high-tech, industrial, and special-hazard end markets across North America, Asia Pacific, and Europe with roughly 29,000 employees. The company is best characterized as a serial acquirer and consolidator of highly fragmented, regulation-driven recurring-service niches — a "platform" model in which inspection and service annuities anchor margins while acquired bolt-ons layer on growth, giving APi a distinct identity versus pure-play contractors. The current investor narrative centers on an accelerating top line (Q3 2026 revenue up 22.5% year-over-year to $2.554 billion) driven by an aggressive acquisition cadence — roughly $1.36 billion deployed across the trailing three quarters — alongside improving gross margins and a post-Q3 stock re-rating. Debate now hinges on whether the deal-driven growth is masking organic deceleration, how quickly acquired EBITDA can be integrated, and whether the balance sheet (debt-to-equity ~0.90x) can absorb further M&A without equity dilution, particularly after a Q4 2025 GAAP loss tied to a large non-cash charge.

People also watch

Quanta Services

Quanta Services

PWR

Analysis
Comfort Systems USA

Comfort Systems USA

FIX

Analysis
EMCOR

EMCOR

EME

Analysis
Jacobs Engineering Group

Jacobs Engineering Group

J

Analysis
MasTec

MasTec

MTZ

Analysis

BobbyInvestment Opinion: Should I buy APG Today?

Rating: Buy (accumulate on weakness). The core thesis is that APi is a compounding, regulation-anchored services consolidator whose 22.5% Q3 2026 revenue growth, expanding gross margin (30.15% vs. 28.39% a year ago), and unanimous Buy/Overweight coverage from all six institutional actions in 2026 outweigh the leverage and integration concerns. Consensus 2027 EPS of $2.73 on $11.65 billion revenue implies roughly 15.9x forward earnings at $43.47 — a reasonable multiple for a mid-teens grower and the cleanest valuation anchor given the distorted trailing PE of -55.4x.

Supporting evidence: (1) valuation is undemanding on sales at 2.01x PS, near the low end of its 1.79x-8.81x historical band, and 15.9x forward EPS is modest for a company growing revenue 22.5%; (2) revenue accelerated sequentially from $1.982B to $2.254B to $2.554B across Q1-Q3 2026, with YoY growth rising from 15.3% to 13.3% to 22.5%; (3) EBITDA margin expanded from 9.33% in Q1 to 11.90% in Q3, showing integration and pricing flowing through; (4) TTM free cash flow of $673 million implies a ~4.2% FCF yield, and the 2027 EPS range of $2.70-$2.78 is only a ~3% spread, signaling high analyst conviction. The main offset is that EV/EBITDA of 18.41x and P/B of 4.67x against an 8.86% ROE are rich versus typical contractor multiples.

Risks and conditions: the three biggest threats are (a) acquisition-dependent growth — ~$1.36 billion deployed in three quarters with organic growth not separately disclosed, (b) leverage at 0.90x debt-to-equity and 52.7% total debt to capitalization, with interest expense climbing from $30M in Q1 to $45M in Q3, and (c) lumpy free cash flow ($198M in Q3 but just $52M in Q2). This Buy would downgrade to Hold if organic growth decelerates below 10% or if EBITDA margin stalls below 11%, and to Sell on a break below the $40.00-$40.50 support shelf toward the $36.76 52-week low. Verdict: fairly valued to modestly undervalued on forward earnings, but expensive on book — a premium that is justified only if margin expansion continues.

Sign up to view all

APG 12-Month Price Forecast

The forward view is constructive but execution-dependent: APi is priced at roughly 15.9x 2027 consensus EPS of $2.73, undemanding for a business that just grew revenue 22.5% and expanded EBITDA margin by 257 basis points sequentially from Q1 to Q3. The recurring inspection-and-service annuity model in Life Safety (~80% of disclosed segment revenue) provides visibility that pure-play contractors lack, and the tight analyst estimate range suggests backlog and acquisition contribution are well understood. The offset is that growth is acquisition-funded, leverage is meaningful, and the stock is extended at ~96% of its 180-day range after a 13% two-day reversal on 11/05. I would upgrade to high confidence if Q4 discloses organic growth above 8% with EBITDA margin above 12.5%, and downgrade to neutral if organic growth falls below 5% or the stock breaks the $40.00-$40.50 support shelf.

Historical Price
Current Price $42.07
Average Target $47.00
High Target $56.00
Low Target $36.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on APi Group Corporation's 12-month outlook, with a consensus price target around $55.18 and implied upside of +31.2% versus the current price.

Average Target

$55.18

11 analysts

Implied Upside

+31.2%

vs. current price

Analyst Count

11

covering this stock

Price Range

$50 - $60

Analyst target range

Buy
11 (100%)
Hold
0 (0%)
Sell
0 (0%)

Coverage is thin at just 3 analysts, but sentiment is uniformly bullish: the institutional ratings feed shows only Buy/Overweight actions from Truist, Citigroup, JP Morgan, Wells Fargo, Barclays, and UBS across 2026, with no Hold or Sell ratings and no downgrades — a clean positive signal, albeit from a small sample. Consensus 2027 EPS estimates average $2.73 (range $2.70-$2.78) on average revenue of $11.65 billion, which against the current $43.47 price implies a forward earnings multiple of roughly 15.9x — a reasonable level for a mid-teens grower and well below the distorted trailing figures. Explicit price targets are not provided in the dataset, so implied upside to a consensus target cannot be calculated; based on the forward EPS and peer multiples, the analyst community appears to view the stock as fairly to modestly undervalued.\n\nThe estimate range is unusually tight — EPS spans just $2.70 to $2.78 (a ~3% spread) and revenue spans $11.56 billion to $11.82 billion (~2% spread) — signaling strong conviction in near-term numbers, likely anchored by backlog and acquisition contribution visibility. The high end of $2.78 EPS would require modest multiple expansion or faster margin capture from recent deals, while the low end of $2.70 would reflect integration friction or slower organic service growth; neither scenario is catastrophic, which is consistent with the uniformly positive ratings. The main caveat is coverage depth: with only 3 analysts and no published target prices in the data, price discovery is less efficient, and the stock's observed 13% two-day swing suggests retail and momentum flows can dominate — investors should treat the bullish consensus as directionally informative but not a precise valuation anchor.

Drowning in data?

Find the real signal!

Bulls vs Bears: APG Investment Factors

The bull case currently has stronger evidence: revenue is accelerating (22.5% YoY in Q3), gross margins are expanding (30.15% vs. 28.39% a year ago), and all six covering institutions rate the stock Buy/Overweight with a tight, high-conviction 2027 EPS consensus of $2.73. The bear case rests less on current performance than on durability — growth is heavily acquisition-driven (~$1.36B deployed in three quarters), margins are thin (3.8% net), and leverage (0.90x D/E) constrains further deal-making without dilution. The single most important tension is whether organic growth can sustain the story if the acquisition cadence slows or credit tightens; that factor, more than any other, would determine whether the 18.41x EV/EBITDA multiple holds or compresses. Valuation is mixed — cheap on sales (2.01x PS near the low end of its 1.79x-8.81x historical band) but rich on book (4.67x P/B near multi-year highs against an 8.86% ROE). Net, the weight of evidence favors the bulls, but the margin of safety is thin and execution-dependent.

Bullish

  • Revenue accelerating to 22.5% YoY: Q3 2026 revenue of $2.554 billion grew 22.49% year-over-year versus $2.085 billion in Q3 2025, an acceleration from Q2's +13.3% and Q1's +15.3%. The sequential climb from $1.982B to $2.254B to $2.554B shows the acquisition engine and underlying service demand compounding together.
  • Gross margin expanding on mix: Q3 2026 gross margin of 30.15% compares favorably to 28.39% in Q3 2025 and 28.10% in Q1 2026, while operating margin rose to 7.91% from 7.52% in Q1. EBITDA margin of 11.90% in Q3 versus 9.33% in Q1 shows integration and pricing are flowing through to profitability.
  • Unanimous bullish analyst coverage: All ratings actions from Truist, Citigroup, JP Morgan, Wells Fargo, Barclays, and UBS across 2026 are Buy/Overweight with zero Hold or Sell ratings and no downgrades. Consensus 2027 EPS of $2.73 on $11.65 billion revenue implies roughly 15.9x forward earnings at $43.47 — reasonable for a mid-teens grower.
  • Tight estimate range signals conviction: The 2027 EPS range spans just $2.70 to $2.78 (~3% spread) and revenue spans $11.56B to $11.82B (~2% spread), signaling strong analyst confidence anchored by backlog and acquisition contribution visibility. Neither the high nor low end implies a catastrophic outcome.

Bearish

  • Growth is acquisition-dependent: Roughly $1.36 billion was deployed across the trailing three quarters (~$540M of Q3 acquisitions and $527M in Q2), meaning deal math is doing much of the heavy lifting on the 22.5% top line. Organic growth is not separately disclosed in the data, raising the question of whether underlying demand is decelerating.
  • Thin margins leave little cushion: Net margin is just 3.8% and operating margin 7.0%, only average for the Engineering & Construction sector. With EV/EBITDA at 18.41x embedding a premium, there is limited room for integration missteps before the multiple compresses.
  • Leverage limits M&A capacity: Debt-to-equity of 0.90x and total debt to capitalization of 52.7% mean further acquisitions may require equity dilution. Interest expense rose to $45 million in Q3 from $30 million in Q1, consuming a meaningful share of $155 million pre-tax income.
  • Lumpy and volatile free cash flow: Quarterly FCF swung from $198 million in Q3 2026 to just $52 million in Q2 and $67 million in Q1 as working capital and integration consumed cash. The 4.2% TTM FCF yield ($673M on ~$15.9B market cap) is modest for a 4.67x P/B stock.

APG Technical Analysis

APG is in a choppy but net-positive recovery uptrend: the stock is up 15.83% over the past year and 11.55% year-to-date, and at $43.47 it sits roughly 96% of the way through its 180-day range (low near $36.76 on 2026-09-16, high near $46.37 on 2026-11-03). That positioning near the top of the range signals momentum leadership rather than deep value, but it also means the stock is extended and vulnerable to profit-taking — the -25.59% max drawdown over the period shows how violently this name can retrace when momentum breaks. The 1-year relative strength versus SPY is a modest +3.56%, so the trend is constructive but not yet a decisive breakout leader.\n\nShort-term momentum is clearly accelerating and diverging positively from the medium-term trend: the stock is up 8.62% over the past month versus a -2.26% decline for SPY, a +10.88% relative-strength spread, while the 3-month change is still -1.09% and the 6-month change just +0.51%. That pattern — strong 1-month, flat 3-6 month — indicates a fresh leg higher off the September/October base rather than a mature trend, with the late-October gap from $41.34 (10/28) to $45.02 (10/29) coinciding with Q3 earnings and follow-through to $46.37 on 11/03. The sharp 11/05 reversal to $40.33 (-13% in two sessions) and subsequent recovery to $43.47 shows high-beta, news-sensitive trading; volume data is unavailable (reported as 0), so price action alone must carry the momentum read.\n\nKey technical levels are well defined: support clusters at the $40.00-$40.50 shelf (repeated closes in October and the 11/05 capitulation low at $40.33), with secondary support at the $36.76 52-week low; resistance sits at the $46.37 high, and a decisive break above it would confirm a new uptrend leg and likely invite momentum buyers. A breakdown below $40 would invalidate the post-earnings breakout and refocus the $36.76-$38.00 zone. Beta is not provided in the dataset, but the observed behavior — a 13% two-day swing and a -25.59% max drawdown — implies materially above-market volatility, warranting smaller position sizing and wider stops than a typical Industrials name.

Beta

1.58

1.58x market volatility

Max Drawdown

-25.6%

Largest decline past year

52-Week Range

$36-$50

Price range past year

Annual Return

+14.4%

Cumulative gain past year

PeriodAPG ReturnS&P 500
1m+4.6%-10.8%
3m+2.2%-9.9%
6m+1.1%-7.5%
1y+14.4%+5.7%
ytd+8.0%+1.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

APG Fundamental Analysis

Revenue is growing briskly and the growth rate is stable-to-accelerating: Q3 2026 revenue of $2.554 billion rose 22.49% year-over-year versus $2.085 billion in Q3 2025, following $2.254 billion in Q2 2026 (+13.3% YoY vs. $1.990 billion) and $1.982 billion in Q1 2026 (+15.3% YoY vs. $1.719 billion). The sequential climb from $1.982B to $2.254B to $2.554B reflects both acquisition contribution (roughly $540M of Q3 acquisitions and $527M in Q2) and solid underlying service demand, with Life Safety at $1.662 billion and Specialty Contracting at $421 million in the disclosed segment split — Life Safety is the dominant growth engine at roughly 80% of segment revenue. The investment case is therefore a compounding acquisition platform story, but investors should watch organic growth disclosure closely since deal math is doing much of the heavy lifting.\n\nProfitability is positive but thin and improving at the gross line: Q3 2026 net income was $114 million (net margin 4.46%) on gross profit of $770 million, a 30.15% gross margin that compares favorably to 28.39% in Q3 2025 and 28.10% in Q1 2026, though slightly below Q2 2026's 31.19%. Operating income of $202 million (7.91% operating margin) and EBITDA of $304 million (11.90% EBITDA margin) show steady expansion from Q1's 7.52% operating margin, while interest expense of $45 million and a 26.5% effective tax rate absorb a meaningful share of pre-tax income ($155 million). The Q4 2025 GAAP EPS of -$1.19 despite $97 million of net income underscores that reported earnings can be distorted by non-cash items, so margin trajectory — not headline EPS — is the better gauge.\n\nThe balance sheet is leveraged but serviceable, and cash generation is lumpy: debt-to-equity is 0.90x (total debt to capitalization 52.7%), current ratio 1.50, and TTM free cash flow of $673 million against a $15.9 billion market cap implies an FCF yield of roughly 4.2%. However, quarterly FCF has been volatile — $198 million in Q3 2026, just $52 million in Q2, and $67 million in Q1 — as working capital and acquisition integration consume cash, and the company spent $186 million on buybacks in Q3 while carrying $373 million of cash. ROE of 8.86% is modest for a 4.67x P/B multiple, and with $1.36 billion of acquisitions funded partly by debt over three quarters, the company is clearly dependent on external financing to sustain its growth model — a key risk if credit conditions tighten.

Quarterly Revenue

$2.6B

2026-09

Revenue YoY Growth

+22.5%

YoY Comparison

Gross Margin

30.1%

Latest Quarter

Free Cash Flow

$673000000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Life Safety
Specialty Contracting

Open an Account, get $2 TSLA now!

Valuation Analysis: Is APG Overvalued?

Because trailing net income is positive ($114 million in Q3 alone) but the trailing PE is reported as -55.4x due to a prior-period loss distortion, the cleanest primary metric here is the price-to-sales ratio of 2.01x, supplemented by EV/EBITDA of 18.41x; the forward PE of -2.39x is not economically meaningful and should be disregarded. The 2.01x PS multiple on a business growing revenue 22.5% is undemanding on the surface, but the 18.41x EV/EBITDA embeds a meaningful premium for a low-margin (7.0% operating margin) services consolidator, implying the market is paying up for the recurring-service and M&A compounding story rather than current earnings.\n\nAgainst the Engineering & Construction industry, APG's 2.01x PS and 18.41x EV/EBITDA sit at a premium to typical contractor multiples (many peers trade in the low-to-mid single digits on EV/EBITDA), reflecting its higher-margin inspection/service mix and acquisition platform; the 4.67x P/B versus an 8.86% ROE is the least flattering comparison, suggesting book value is richly valued relative to returns. The premium is partially justified by superior growth (22.5% revenue growth) and recurring revenue characteristics, but the 31.4% gross margin and 3.8% net margin are only average for the sector, so the multiple leaves limited room for integration missteps.\n\nOn its own history, APG is trading near the upper end of its valuation band: PS has ranged from roughly 1.79x (Q3 2022) to 8.81x (Q1 2026), and the current 2.01x is near the low end of that range, while P/B of 4.67x compares to a 2022-2023 range of 1.05x-4.22x and is near multi-year highs. The divergence — cheap on sales, expensive on book — reflects margin expansion and acquisition-driven revenue growth since 2022, but also means the stock is priced for continued execution; a return to the 2023-era 2.0x-2.8x P/B band would imply substantial downside, while sustained EBITDA margin expansion toward the mid-teens would support the current EV/EBITDA.

PE

-55.4x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 32x~100x

vs. Industry Avg

27.6x

Industry PE ~27.6x*

EV/EBITDA

18.4x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on the balance sheet's dependence on external financing to sustain the growth model. Debt-to-equity of 0.90x and total debt to capitalization of 52.7% mean the ~$1.36 billion of acquisitions over three quarters was funded partly by debt, and interest expense climbed from $30 million in Q1 to $45 million in Q3, absorbing a large share of $155 million pre-tax income. Free cash flow is lumpy — $198 million in Q3 but only $52 million in Q2 and $67 million in Q1 — as working capital and integration consume cash, and net margin of just 3.8% leaves little buffer if acquired EBITDA fails to materialize. Reported earnings are also distortion-prone: Q4 2025 posted a GAAP EPS of -$1.19 despite $97 million of net income due to a large non-cash charge, so headline EPS is an unreliable gauge of underlying performance.

Market and competitive risks stem from a premium multiple applied to average sector margins. EV/EBITDA of 18.41x sits well above typical contractor multiples in the low-to-mid single digits, and P/B of 4.67x against an 8.86% ROE is the least flattering comparison, implying the market is paying up for the recurring-service and M&A compounding narrative rather than current earnings. Beta is not provided, but the observed -25.59% max drawdown and a 13% two-day swing imply materially above-market volatility, and the stock's 1-year relative strength versus SPY is only +3.56% — constructive but not decisive leadership. Coverage is thin at just 3 analysts with no published price targets in the data, so price discovery is inefficient and momentum flows can dominate; any integration stumble or organic deceleration headline could trigger outsized selling.

In a worst-case scenario, a credit tightening that forces APi to slow acquisitions, combined with organic service growth decelerating and integration friction compressing EBITDA margins, would hit the stock on both earnings and multiple. The realistic downside is a retest of the $36.76 52-week low (2026-09-16), roughly -15% from the current $43.47, and a break below the $40.00-$40.50 support shelf would likely accelerate selling toward the $36.76-$38.00 zone. In a more severe de-rating where the multiple compresses toward peer levels, the -25.59% max drawdown observed over the period implies a loss of roughly -26% from current levels, and a return to the 2023-era 2.0x-2.8x P/B band would imply substantially deeper downside than that.

FAQ

The most severe risk is the acquisition-dependent growth model: roughly $1.36 billion was deployed across three quarters, organic growth is not separately disclosed, and debt-to-equity of 0.90x with total debt at 52.7% of capitalization means further deals may require dilutive equity issuance. Second is margin and earnings fragility — net margin is just 3.8% and operating margin 7.0%, so integration friction or pricing pressure could quickly compress the 18.41x EV/EBITDA multiple, and reported EPS is already distortion-prone (Q4 2025 showed -$1.19 GAAP EPS despite $97 million of net income). Third is balance-sheet cost creep, with interest expense rising from $30 million in Q1 to $45 million in Q3 against $155 million of pre-tax income, plus lumpy free cash flow that swung from $198 million in Q3 to $52 million in Q2. Fourth is market and liquidity risk: thin coverage of just 3 analysts with no published price targets, a -25.59% max drawdown, and a 13% two-session reversal on 11/05 imply high volatility and momentum-driven price action that can punish holders on any headline.

The 12-month forecast splits into three scenarios weighted toward the middle. The base case carries 55% probability with a $44-$50 target range, assuming 2027 EPS near the $2.73 consensus on $11.65 billion revenue, EBITDA margin holding in the 11.5%-12.5% band, and debt-to-equity staying near 0.90x without a large equity raise. The bull case at 25% probability targets $52-$56, driven by acquired EBITDA integrating faster toward mid-teens margins, organic service growth in the high single digits, and a re-rating to roughly 19-20x forward earnings on the high end of $2.78 EPS. The bear case at 20% probability targets $36-$40, reflecting credit tightening that slows M&A, organic deceleration below 5%, and margin compression back toward the 9.33% Q1 level, with a retest of the $36.76 52-week low. The base case is most likely because the tight ~3% analyst EPS spread signals backlog and acquisition contribution are well understood, and 15.9x forward earnings already reflects a reasonable, not heroic, growth assumption.

The valuation picture is genuinely mixed rather than cleanly cheap or expensive. On sales, APG at 2.01x PS sits near the low end of its historical 1.79x-8.81x band, which looks undemanding for a business growing revenue 22.5%, and the ~15.9x forward multiple on 2027 EPS of $2.73 is modest for a mid-teens grower. However, EV/EBITDA of 18.41x embeds a meaningful premium for a company with only a 7.0% operating margin, and P/B of 4.67x against an 8.86% ROE is near multi-year highs versus a 2022-2023 range of 1.05x-4.22x. The trailing PE of -55.4x and forward PE of -2.39x are distorted by prior-period losses and should be disregarded in favor of the forward EPS and PS metrics. What the market is implicitly pricing is continued EBITDA margin expansion toward the mid-teens and sustained acquisition contribution; if margins stall near 11-12%, the current multiple looks full, while delivery of mid-teens margins would justify it. Net, the stock appears fairly valued to modestly undervalued on forward earnings but expensive on book value.

From a risk/reward standpoint APG offers a reasonable but not exceptional setup: at $43.47 it trades at roughly 15.9x consensus 2027 EPS of $2.73 and 2.01x sales, near the low end of its 1.79x-8.81x historical PS band, while revenue is accelerating at 22.5% year-over-year and EBITDA margin has expanded from 9.33% in Q1 to 11.90% in Q3 2026. All six institutional ratings actions in 2026 were Buy/Overweight with no downgrades, and the 2027 EPS estimate range of $2.70-$2.78 is only a 3% spread, signaling high analyst conviction. The offset is that growth is heavily acquisition-funded ($1.36 billion deployed in three quarters), leverage sits at 0.90x debt-to-equity with interest expense rising to $45 million in Q3, and the stock is extended at ~96% of its 180-day range after a 13% two-day reversal on 11/05. The biggest downside risk is a retest of the $36.76 52-week low, roughly -15% from current levels, or a deeper -26% de-rating matching the observed max drawdown. It is a good buy for investors with a multi-year horizon who can tolerate above-market volatility and who accumulate on weakness toward the $40.00-$40.50 support shelf rather than chasing strength above $46.

APG is better suited to a long-term holding period of at least two to three years than to short-term trading. The thesis depends on multi-year compounding from acquisition integration and margin expansion — EBITDA margin moving from 9.33% in Q1 to 11.90% in Q3 2026 is a trend, not a single event — and the recurring inspection and service annuity model in Life Safety provides the earnings visibility that rewards patience. The stock pays no dividend (0% yield, 0% payout ratio), so total return depends entirely on price appreciation and reinvested M&A, which argues for a growth-oriented, longer-horizon holder. Short-term trading is hazardous: the stock suffered a -25.59% max drawdown and a 13% two-session reversal on 11/05, and with volume data unavailable and only 3 analysts covering it, price discovery is inefficient and momentum flows dominate. A concrete approach is a minimum 24-36 month holding period, accumulating on pullbacks toward the $40.00-$40.50 support shelf and reassessing if organic growth falls below 5% or EBITDA margin stalls below 11%.